Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
Other
Atara Biotherapeutics Inc
Other Peer Comparison
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Other
$821k
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other
-$742m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-9%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other
-$278m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other
-$134m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other
-$226.1m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-68%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other
-$947.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
See Also
What is Atara Biotherapeutics Inc's Other?
Other
821k
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Other amounts to 821k USD.
What is Atara Biotherapeutics Inc's Other growth rate?
Other CAGR 5Y
-46%
Over the last year, the Other growth was -97%. The average annual Other growth rates for Atara Biotherapeutics Inc have been -45% over the past three years , -46% over the past five years .